| Trial ID: | L6166 |
| Source ID: | NCT01183715
|
| Associated Drug: |
Pf-05161704 Or Placebo
|
| Title: |
A Single Dose Study Of PF-05161704 In Healthy Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: PF-05161704 or placebo|DRUG: PF-05161704 or placebo
|
| Outcome Measures: |
Primary: Safety and tolerability of escalating single oral doses of PF-05161704 in healthy subjects, 1 month|Single dose pharmacokinetics of PF-05161704 and its metabolite PF-05200145, 1 month | Secondary: Preliminary pharmacodynamics of PF-05161704, 1 month
|
| Sponsor/Collaborators: |
Sponsor: Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-07
|
| Completion Date: |
2010-09
|
| Results First Posted: |
|
| Last Update Posted: |
2019-07-23
|
| Locations: |
Pfizer Investigational Site, New Haven, Connecticut, 06511, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01183715
|
